Clinical Trials Browser

Phase 2 × mavrilimumab × Clear all

NCT01715896 2016-10-31

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

Phase 2 Completed

215 enrolled 37 charts

Arthritis, Rheumatoid